Provided by Tiger Trade Technology Pte. Ltd.

The India Fund Inc

10.45
-0.1900-1.79%
Post-market: 10.450.00000.00%16:15 EDT
Volume:397.68K
Turnover:4.18M
Market Cap:452.58M
PE:-4.57
High:10.64
Open:10.59
Low:10.45
Close:10.64
52wk High:15.47
52wk Low:10.45
Shares:43.31M
Float Shares:43.31M
Volume Ratio:2.09
T/O Rate:0.92%
Dividend:2.12
Dividend Rate:20.25%
EPS(TTM):-2.2848
EPS(LYR):-1.1125
ROE:-15.90%
ROA:-0.33%
PB:0.83
PE(LYR):-9.39

Loading ...

Press Release: Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details

Dow Jones
·
Yesterday

PAC Partners Sticks to Its Buy Rating for Infragreen Group Limited (IFN)

TIPRANKS
·
Sep 01

Infragreen Group Expands ASX-Quoted Share Base With 24.9m New IFN Securities

TIPRANKS
·
Aug 31

Analyst Reiterates Buy on IFN After Stronger‑Than‑Expected FY26 Results, Upgraded Outlook and Potential Upside from Pure Environmental Sale

TIPRANKS
·
Aug 27

We're Interested To See How Infragreen Group (ASX:IFN) Uses Its Cash Hoard To Grow

Simply Wall St.
·
Aug 27

Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

Reuters
·
Aug 12

Protara Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update

GlobeNewswire
·
Aug 11

Press Release: Aberdeen Investments U.S. Closed-end Funds Announce Distribution Payment Details

Dow Jones
·
Jul 01

Aberdeen India Fund Director of Adviser Steven Maguire Files Initial Beneficial Ownership Statement

Reuters
·
Jun 25

India's NIFTY 50 Index Records 1.2% Decline

Deep News
·
Jun 23

INSTANT VIEW-India's economy grows 7.8% in January-March

Reuters
·
Jun 05

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

GlobeNewswire
·
Jun 04

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus

GlobeNewswire
·
Jun 01

Press Release: ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERS

Dow Jones
·
May 28

Protara Therapeutics to Host Virtual Investor Webinar to Discuss TARA-002 for Lymphatic Malformations on Tuesday, May 19, 2026

GlobeNewswire
·
May 18

Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update

GlobeNewswire
·
May 13

Press Release: Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

Dow Jones
·
May 12

Press Release: Protara Therapeutics to Present Updated, Interim 12-Month Data from the Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the American Urological Association Annual Meeting

Dow Jones
·
Apr 28

India Is Pitching Wall Street. What to Be Careful Of. -- Barrons.com

Dow Jones
·
Apr 10

Aberdeen India Fund announces annual shareholder meeting

Reuters
·
Apr 08